Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Definium Therapeutics Inc

CUSIP: 8808789TT | 1 institutional holders

Quarters

Compare Detailed Historical Funds Options Short Interest 13D/13G Peers Targeting Trading Summary Profile